两种方法治疗复发性生殖器疱疹疗效及对细胞免疫功能的影响

目的 探讨两种方法治疗复发性生殖器疱疹(RGH)患者疗效及对T细胞亚群的影响.方法 64例RGH患者随机分为联合治疗组32例、对照组32例,对照组口服伐昔洛韦片治疗,联合治疗组除口服伐昔洛韦片外,还接受乌体林斯注射液治疗,观察两组的治疗效果,并检测治疗前后T细胞亚群情况.结果 联合治疗组治疗后RGH复发频率[(1.01±0.79)次/年]较对照组[(2.53±0.93)次/年]明显下降(P<0.01);联合治疗组治疗后CD+4T细胞数[(40.38±6.85)%]及CD+4/CD+8比值(1.59±0.50)均较对照组[(36.28±6.76)%,(1.28±0.49)%]明显升高(P<0.05),CD+8细胞数[(26.32±6.05)%]较对照组[(29.73±5.49)%]明显下降(P<0.05).结论 RGH患者存在细胞免疫功能异常,伐昔洛韦联合乌体林斯治疗RGH,可以增强细胞免疫,提高治疗效果.

The influence of curative effect and cellular immune function in patients with recurrent genital herpes by two methods

Objective To explore the influence of the treatment and T-cell subsets in patients with recurrent genital herpes (RGH) by two treatment methods. Methods 64 cases of RGH patients were randomly divided int0 2 groups: 32 patients in the unite treatment group, the control group of 32 patients. Control group oral valaciclovir. The unite treatment group of oral valaciclovir tablets, in addition, also accepted mycobacterium phle injection treatment. All the patients before and after treatment were analyzed by flow cytometry using T-cell subsets. Results In the unite treatment group after treatment RGH relapse frequency [(1.01±0.79)] than that of the control group [(2.53±0.93)] was significantly decreased (P<0.001). In the unite treatment group after treatment CD+4 T cells and CDCD+4/CDCD+8 ratio than the control group were significantly increased (P<0.05), CD+8 cells compared with the control group was significantly decreased (P<0.05). Conclusion The cellular immunity is abnormal in RGH patients and it plays an important role in pathogenesis of RGH. Mycobacterium phle may enhance cellular immunity of the patients and these patients treated with it showed some better effects.